We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
-0.74%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$17.1B
AUM Growth
+$2.54B
Cap. Flow
-$40.7M
Cap. Flow %
-0.24%
Top 10 Hldgs %
21.61%
Holding
2,194
New
682
Increased
333
Reduced
357
Closed
710
Avg Time Held Equity + Options
1.8 quarters
Top 10 Avg Time Held Equity + Options
0.6 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
1.5 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$128M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$124M
3
NFLX icon
Netflix
NFLX
+$48.3M
4
MSFT icon
Microsoft
MSFT
+$33M
5
BMY icon
Bristol-Myers Squibb
BMY
+$31.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.8%
2 Technology 2.44%
3 Healthcare 2.37%
4 Consumer Discretionary 1.9%
5 Financials 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EOSE icon
176
CALL
Eos Energy Enterprises
EOSE
$845M
$20.8M 0.12%
4,190,400
-998,000
-19% -$10.7M
2023 Q2
11 quarters
ISRG icon
177
PUT
Intuitive Surgical
ISRG
$149B
$20.7M 0.12%
45,000
+11,800
+36% +$5.97M
2025 Q4
1 quarter
XENE icon
178
PUT
Xenon Pharmaceuticals
XENE
$3.33B
$20.7M 0.12%
355,700
+65,700
+23% +$3.03M
2025 Q2
3 quarters
PTCT icon
179
CALL
PTC Therapeutics
PTCT
$5B
$20.6M 0.12%
302,100
+202,100
+202% +$14.3M
2025 Q2
3 quarters
CVS icon
180
PUT
CVS Health
CVS
$112B
$20.5M 0.12%
284,900
+184,900
+185% +$14.2M
2024 Q4
5 quarters
DHT icon
181
CALL
DHT Holdings
DHT
$4.29B
$20.4M 0.12%
1,118,200
+1,099,200
+5,785% +$17.5M
2025 Q3
2 quarters
NFLX icon
182
Netflix
NFLX
$293B
$20.4M 0.12%
212,100
-548,000
-72% -$48.3M
2025 Q4
1 quarter
TEVA icon
183
PUT
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
$20.3M 0.12%
+674,500
New +$21.7M
2026 Q1
0 quarters
TVTX icon
184
CALL
Travere Therapeutics
TVTX
$4.88B
$20.2M 0.12%
681,000
+14,600
+2% +$436K
2024 Q3
6 quarters
ECHO icon
185
CALL
EchoStar
ECHO
$26.6B
$20.1M 0.12%
172,000
-769,100
-82% -$88.3M
2024 Q3
6 quarters
KALV icon
186
PUT
DELISTED
KalVista Pharmaceuticals
KALV
$20.1M 0.12%
+1,000,000
New +$16.1M
2026 Q1
0 quarters
CEG icon
187
Constellation Energy
CEG
$105B
$20.1M 0.12%
71,923
+59,773
+492% +$18.2M
2025 Q4
1 quarter
IMCR icon
188
Immunocore
IMCR
$1.43B
$20M 0.12%
661,786
+567,402
+601% +$18.4M
2025 Q1
4 quarters
SWK icon
189
Stanley Black & Decker
SWK
$13.7B
$19.9M 0.12%
+280,463
New +$22.5M
2026 Q1
0 quarters
TSM icon
190
PUT
TSMC
TSM
$2.31T
$19.9M 0.12%
58,900
-6,100
-9% -$2.1M
2025 Q1
4 quarters
BMY icon
191
CALL
Bristol-Myers Squibb
BMY
$116B
$19.7M 0.12%
325,000
+150,000
+86% +$8.74M
2024 Q3
6 quarters
CRWV icon
192
PUT
CoreWeave
CRWV
$42.9B
$19.4M 0.11%
250,000
-213,600
-46% -$18.5M
2025 Q2
3 quarters
LUNR icon
193
CALL
Intuitive Machines
LUNR
$1.97B
$19.3M 0.11%
1,040,000
+117,000
+13% +$2.16M
2025 Q3
2 quarters
RTX icon
194
PUT
RTX Corp
RTX
$247B
$19.3M 0.11%
+100,000
New +$19.9M
2026 Q1
0 quarters
NN icon
195
CALL
NextNav
NN
$1.91B
$19.3M 0.11%
1,202,200
-90,000
-7% -$1.46M
2023 Q4
9 quarters
IRON icon
196
CALL
Disc Medicine
IRON
$2.17B
$19.2M 0.11%
+300,000
New +$20.8M
2026 Q1
0 quarters
BABA icon
197
CALL
Alibaba
BABA
$276B
$18.8M 0.11%
150,000
+30,000
+25% +$4.51M
2024 Q4
5 quarters
BP icon
198
CALL
BP
BP
$125B
$18.8M 0.11%
+400,000
New +$15.7M
2026 Q1
0 quarters
C icon
199
CALL
Citigroup
C
$209B
$18.7M 0.11%
165,000
-180,000
-52% -$20.5M
2025 Q3
2 quarters
ZVRA icon
200
PUT
Zevra Therapeutics
ZVRA
$617M
$18.7M 0.11%
2,002,800
+901,600
+82% +$8.13M
2025 Q1
4 quarters

Similar funds

Caption Management's Q1 2026 Portfolio in Review

As of Q1 2026, Caption Management held 2,194 positions worth $17.1B, up 17% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Caption Management's Q1 2026 filing shows 682 new, 333 increased, 357 reduced and 710 closed positions. Its largest new stake was Meta Platforms (Facebook): 112,500 shares worth $64.4M. The largest sale was Apple, an estimated $128M.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 85% a quarter earlier, followed by Technology and Healthcare.

  • Caption Management's largest Q1 2026 buy was Meta Platforms (Facebook): 112,500 shares worth $64.4M.
  • Caption Management added most to Blue Owl Capital in Q1 2026, an estimated $166M increase.
  • Caption Management's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $124M.
  • Caption Management fully exited Apple in Q1 2026, selling an estimated $128M.
  • Caption Management's ten largest holdings make up 22% of its $17.1B portfolio in Q1 2026.
  • Caption Management opened 682 new positions and closed 710 in Q1 2026.
  • Caption Management's portfolio value rose 17% quarter-over-quarter to $17.1B.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.